IL23R and inflammatory bowel disease: Genetic variants in IL-23R have been shown to have a robust association with the development of autoimmune disorders, with a notable prevalence observed in diseases such as ankylosing spondylitis, rheumatoid arthritis, psoriasis, and inflammatory bowel diseases (IBD) including Crohn’s disease and ulcerative colitis.